{
    "clinical_study": {
        "@rank": "77089", 
        "acronym": "SAGA", 
        "arm_group": [
            {
                "arm_group_label": "Development group 1"
            }, 
            {
                "arm_group_label": "Development group 2"
            }, 
            {
                "arm_group_label": "Development group 3"
            }, 
            {
                "arm_group_label": "Validation group"
            }
        ], 
        "biospec_descr": {
            "textblock": "DNA, RNA"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study will prospectively enroll approximately 660 children, at least 18 months and less\n      than 5 years of age, who have been referred to a pediatric developmental evaluation centers.\n       Enrolled children will have blood drawn for RNA gene expression analysis and undergo a\n      clinical evaluation to determine the presence or absence of a diagnosis of ASD.\n\n      The sequential co-primary objectives of this study are:\n\n        -  To develop an algorithm to classify blood RNA gene expression patterns to maximize\n           agreement between the classification and a clinical assessment of presence or absence\n           of Autism Spectrum Disorders (ASD).\n\n        -  To prospectively assess the clinical sensitivity and specificity of the blood RNA gene\n           expression classification algorithm (the SDX-002 test) in children referred to a\n           developmental evaluation clinic for a possible developmental disorder."
        }, 
        "brief_title": "SynapDx Autism Gene Expression Analysis Study", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Autism", 
        "condition_browse": {
            "mesh_term": [
                "Autistic Disorder", 
                "Child Development Disorders, Pervasive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Referred to a developmental evaluation centers for evaluation of a possible\n             developmental disorder, other than isolated motor problems.\n\n          2. Age >= 18 months and < 5 years.\n\n          3. Parent/legal guardian has been informed about the study and has signed an informed\n             consent form.\n\n        Exclusion Criteria:\n\n          1. Prior reliable diagnosis of Autism Spectrum Disorder (i.e. prior evaluation by a\n             multi-disciplinary team has already reliably established Autism Spectrum Disorder\n             diagnosis).\n\n          2. Unable or unwilling to complete study procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "18 Months", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Children 18 months to < 5 years referred to a developmental evaluation centers for\n        evaluation of a possible developmental disorder."
            }
        }, 
        "enrollment": {
            "#text": "660", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01716845", 
            "org_study_id": "12001"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "autism", 
            "autism spectrum disorders", 
            "RNA", 
            "gene expression", 
            "developmental delay"
        ], 
        "lastchanged_date": "March 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Children's Hospital Boston"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "4", 
        "official_title": "SynapDx Autism Spectrum Disorder Gene Expression Analysis Study", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "RNA gene expression in peripheral blood", 
            "safety_issue": "No", 
            "time_frame": "within 30 days of collection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01716845"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "SynapDx", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "SynapDx", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}